Complete STD Profile
Take a proactive approach to your sexual health with PhlebCARE’s Comprehensive STD/STI Screening Panel. This seven-test-group package screens for common sexually transmitted infections, including chlamydia, gonorrhea, trichomoniasis, HIV, syphilis, herpes, and viral hepatitis. It also includes a complete blood count and urinalysis for additional health insights, with convenient and confidential specimen collection options.
What’s Included
| ✓ |
Chlamydia, Gonorrhea & Trichomonas, NAA
Nucleic acid amplification testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.
|
| ✓ |
Complete Blood Count (CBC) With Differential
Measures red and white blood cells, hemoglobin, and platelets for a general assessment of blood health. It is not a specific STI screening test.
|
| ✓ |
Hepatitis Panel (HAV, HBVc, HBsAg, HCV)
Includes the specified hepatitis A, hepatitis B, and hepatitis C markers. Interpretation depends on the exact antibody and antigen assays ordered.
|
| ✓ |
Herpes Simplex Virus (HSV-1 & HSV-2), Type-Specific IgG
Detects type-specific antibodies that may indicate prior exposure to HSV-1 or HSV-2. It does not determine when infection occurred or identify the site of infection.
|
| ✓ |
HIV Fourth-Generation Antigen/Antibody With Reflex
Screens for HIV-1/2 antibodies and HIV-1 p24 antigen, with additional testing according to laboratory reflex criteria.
|
| ✓ |
Treponema pallidum Antibodies
Screens for antibodies associated with syphilis. Additional testing may be needed to determine infection status or treatment history.
|
| ✓ |
Complete Urinalysis With Microscopic Examination
Evaluates urine characteristics and microscopic findings for possible urinary tract, kidney, and other health abnormalities. It does not replace STI-specific testing.
|
Who May Benefit?
Understanding STI Screening
Many sexually transmitted infections can occur without noticeable symptoms. Laboratory screening may help identify infections so that appropriate medical evaluation, treatment, and partner notification can occur.
This panel combines nucleic acid amplification testing, antigen and antibody screening, and general blood and urine health measurements.
The appropriate testing method and specimen collection site depend on the type of exposure. Urine testing alone may not identify infections in the throat or rectum, and additional site-specific swabs may be recommended.
Preparation Instructions
Fasting is not routinely required for the tests listed in this panel unless your healthcare provider or laboratory instructs otherwise.
Drink water normally before your appointment. Avoid excessive fluid intake immediately before urine collection unless instructed otherwise.
The STI urine specimen may require first-catch urine, while the complete urinalysis may require a separate clean-catch specimen. Follow the specific instructions provided for each test. You may be asked not to urinate for at least one hour before the STI sample.
Inform your healthcare provider about recent antibiotic or antiviral treatment. Continue prescribed medications unless your provider instructs otherwise.
Bring valid identification and any required laboratory documentation.
Collection Details
This panel requires blood and urine specimens. Depending on exposure history and the laboratory order, additional collection methods or site-specific testing may be appropriate.
PhlebCARE offers in-clinic and mobile specimen collection where available. Our team will confirm collection requirements, appointment details, and applicable services during order coordination.
Important Notes
Testing Windows: Some infections may not be detectable immediately after exposure. A negative result obtained too early may require repeat testing at an appropriate interval.
HSV Antibody Testing: HSV IgG testing does not identify an active outbreak. False-positive results can occur, particularly with low-positive HSV-2 results, and confirmatory testing may be appropriate. Routine HSV blood screening is not recommended for all asymptomatic individuals.
Hepatitis Screening: The interpretation of hepatitis markers depends on the exact assays included. A positive hepatitis C antibody result may require HCV RNA testing to determine whether infection is current.
Recent HIV Exposure: If a possible HIV exposure occurred within the past 72 hours, seek urgent medical evaluation for post-exposure prophylaxis (PEP) rather than waiting for routine screening.
This panel does not screen for every STI. Results should be reviewed with a qualified healthcare provider to determine whether additional testing, treatment, or follow-up is needed.
Pricing & Service Availability
PhlebCARE offers in-clinic and mobile specimen collection, subject to location, laboratory requirements, and scheduling availability. Collection, processing, travel, or additional laboratory fees may apply and will be confirmed during order coordination.
